A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned

Availability of integrase strand transfer inhibitors created interest in determining whether their use would decrease persistently infected cell numbers. This study hypothesized that adding raltegravir (RAL) to standard antiretroviral therapy (ART) would decrease human immunodeficiency virus (HIV)-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Collier, Ann C., Chun, Tae-Wook, Maenza, Janine, Coombs, Robert W., Tapia, Kenneth, Chang, Ming, Stevens, Claire E., Justement, J. Shawn, Murray, Danielle, Stekler, Joanne D., Mullins, James I, Holte, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744890/
https://www.ncbi.nlm.nih.gov/pubmed/26862469
http://dx.doi.org/10.1089/biores.2015.0038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744890/
https://www.ncbi.nlm.nih.gov/pubmed/26862469
http://dx.doi.org/10.1089/biores.2015.0038

Ejemplares similares